Out-of-Pocket Costs of Specialty Medications for Psoriasis and Psoriatic Arthritis Treatment in the Medicare Population-Reference-Cited by-同舟云学术

Out-of-Pocket Costs of Specialty Medications for Psoriasis and Psoriatic Arthritis Treatment in the Medicare Population

Published:2021-10-01 Issue:10 Volume:157 Page:1239
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Pourali Sarah P.¹,Nshuti Leonce²,Dusetzina Stacie B.²

Affiliation:

1. Vanderbilt University School of Medicine, Nashville, Tennessee

2. Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2784292/jamadermatology_pourali_2021_ld_210020_1634154577.1255.pdf

Reference6 articles.

1. Psoriasis and comorbid diseases: Epidemiology.;Takeshita;J Am Acad Dermatol,2017

2. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.;Gottlieb;J Am Acad Dermatol,2008

3. Health care utilization and cost associated with biologic treatment patterns among patients with moderate to severe psoriasis: analyses from a large U.S. claims database.;Feldman;J Manag Care Spec Pharm,2018

4. Compliance with biologic therapies for rheumatoid arthritis: do patient out-of-pocket payments matter?;Curkendall;Arthritis Rheum,2008

5. Off-label biologic regimens in psoriasis: a systematic review of efficacy and safety of dose escalation, reduction, and interrupted biologic therapy.;Brezinski;PLoS One,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A secret shopper study of psoriasis assistance programs shows enrollment and communication challenges;Archives of Dermatological Research;2024-08-17

2. Use of Efficiency Frontiers to Align Prices and Clinical Benefits of Biologic Therapies for Plaque Psoriasis;JAMA Dermatology;2024-04-01

3. Medicare Part D Coverage of Drugs Selected for the Drug Price Negotiation Program;JAMA Health Forum;2024-02-09

4. Analyzing Access and Costs of Oral Medications for Overactive Bladder: Uncovering Disparities;Urology;2024-01

5. Modeling Posttreatment Prognosis of Skin Lesions in Patients With Psoriasis in China;JAMA Network Open;2023-04-06